Li Hua Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Li Hua Jin has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
Shichao Yu
College of Life Science, Northeast Forestry University, Harbin 150040, China
7 shared publicationsFangzhou Luo
College of Life Sciences, Northeast Forestry University, Harbin, 150040, China
6 shared publicationsJiewei Wang
College of Life Science, Northeast Forestry University, Harbin, China
4 shared publicationsPing Wang
College of Life Sciences, Northeast Forestry University, Harbin, China
4 shared publicationsYangguang Hao
Department of Basic Medical Shenyang Medical College Shenyang China
4 shared publicationsChengcheng Zhang
College of Life Sciences, Northeast Forestry University, Harbin, 150040, China
3 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (11) , 103117
Microbiota-derived SCFAs modulate Socs36E-mediated feedback to regulate intestinal stem cell proliferation upon Atg4 loss in Drosophila
- 15 October 2026
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (11) , 103117
Open AccessMicrobiota-derived SCFAs modulate Socs36E-mediated feedback to regulate intestinal stem cell proliferation upon Atg4 loss in Drosophila
- Open Access
- 31 August 2026
- Published by Springer Nature in Microbiome
- Vol. 14 (1) , 208
Correction: Atg2 coordinates microbial metabolite signaling and epigenetic remodeling to maintain intestinal lipid homeostasis in Drosophila
- 31 August 2026
- Published by Springer Nature in Microbiome
- Vol. 14 (1) , 208
Open AccessCorrection: Atg2 coordinates microbial metabolite signaling and epigenetic remodeling to maintain intestinal lipid homeostasis in Drosophila
- 6 May 2026
- Published by Elsevier in Experimental Cell Research
- Vol. 460 (1) , 115060
Tsc1 and Tsc2 maintain hematopoietic homeostasis through multiple signaling pathways in Drosophila
- 6 May 2026
- Published by Elsevier in Experimental Cell Research
- Vol. 460 (1) , 115060
Tsc1 and Tsc2 maintain hematopoietic homeostasis through multiple signaling pathways in Drosophila
- Open Access
- 27 March 2026
- Published by Springer Nature in Microbiome
- Vol. 14 (1)
Atg2 coordinates microbial metabolite signaling and epigenetic remodeling to maintain intestinal lipid homeostasis in Drosophila
Background: The autophagy-related protein Atg2 maintains intestinal homeostasis by preventing lipid accumulation and microbial dysbiosis; however, the mechanisms by which these pathologies interconnect remain unknown. Results: We identify a microbiota‒metabolite‒epigenome axis through which Atg2 deficiency triggers metabolic‒immune cascades in the Drosophila intestine. Tissue-specific Atg2 depletion disrupts autophagic flux, provoking commensal overgrowth and pathogenic overproduction of short-chain fatty acids (SCFAs). Elevated SCFAs drive acetyl-CoA overflow, inducing global protein hyperacetylation that simultaneously activates lipogenic programs and primes innate immunity. Crucially, microbiota ablation or SCFAs restriction fully reverses lipid–immune dysregulation, mechanistically linking microbial metabolites to host pathophysiology. Conclusions: Our work establishes Atg2 as a guardian of microbiota-derived metabolite signaling, demonstrating that autophagy constrains microbial byproducts to prevent acetyl-CoA-mediated epigenetic hijacking of metabolic and immune networks. These findings reveal protein acetylation as a convergent regulator linking commensal ecology to host physiology, suggesting metabolite-centric therapies for dysbiosis-associated disorders.
- 27 March 2026
- Published by Springer Nature in Microbiome
- Vol. 14 (1)
Open AccessAtg2 coordinates microbial metabolite signaling and epigenetic remodeling to maintain intestinal lipid homeostasis in Drosophila
Background: The autophagy-related protein Atg2 maintains intestinal homeostasis by preventing lipid accumulation and microbial dysbiosis; however, the mechanisms by which these pathologies interconnect remain unknown. Results: We identify a microbiota‒metabolite‒epigenome axis through which Atg2 deficiency triggers metabolic‒immune cascades in the Drosophila intestine. Tissue-specific Atg2 depletion disrupts autophagic flux, provoking commensal overgrowth and pathogenic overproduction of short-chain fatty acids (SCFAs). Elevated SCFAs drive acetyl-CoA overflow, inducing global protein hyperacetylation that simultaneously activates lipogenic programs and primes innate immunity. Crucially, microbiota ablation or SCFAs restriction fully reverses lipid–immune dysregulation, mechanistically linking microbial metabolites to host pathophysiology. Conclusions: Our work establishes Atg2 as a guardian of microbiota-derived metabolite signaling, demonstrating that autophagy constrains microbial byproducts to prevent acetyl-CoA-mediated epigenetic hijacking of metabolic and immune networks. These findings reveal protein acetylation as a convergent regulator linking commensal ecology to host physiology, suggesting metabolite-centric therapies for dysbiosis-associated disorders.
- 28 March 2025
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 61 (2) , 401-404
Synthesis and Nematicide Activities of β-Sitosterol Ester Derivatives
- 28 March 2025
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 61 (2) , 401-404
Synthesis and Nematicide Activities of β-Sitosterol Ester Derivatives
- Open Access
- 14 November 2024
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 24 (1) , 1-19
Extracts ofHylotelephiumerythrostictum (miq.) H. Ohba ameliorate intestinal injury by scavenging ROS and inhibiting multiple signaling pathways in Drosophila
Background: The intestinal epithelial barrier is the first line of defense against pathogens and noxious substances entering the body from the outside world. Through proliferation and differentiation, intestinal stem cells play vital roles in tissue regeneration, repair, and the maintenance of intestinal homeostasis. Inflammatory bowel disease (IBD) is caused by the disruption of intestinal homeostasis through the invasion of toxic compounds and pathogenic microorganisms. Hylotelephium erythrostictum (Miq.) H. Ohba (H. erythrostictum) is a plant with diverse pharmacological properties, including antioxidant, anti-inflammatory, antidiabetic, and antirheumatic properties. However, the roles of H. erythrostictum and its bioactive compounds in the treatment of intestinal injury are unknown. Methods: We examined the protective effects of H. erythrostictum water extract (HEWE) and H. erythrostictum butanol extract (HEBE) on Drosophila intestinal injury caused by dextran sodium sulfate (DSS) or Erwinia carotovoracarotovora 15 (Ecc15). Results: Our findings demonstrated that both HEWE and HEBE significantly prolonged the lifespan of flies fed toxic compounds, reduced cell mortality, and maintained intestinal integrity and gut acid‒base homeostasis. Furthermore, both HEWE and HEBE eliminated DSS-induced ROS accumulation, alleviated the increases in antimicrobial peptides(AMPs) and intestinal lipid droplets caused by Ecc15 infection, and prevented excessive ISC proliferation and differentiation by inhibiting the JNK, EGFR, and JAK/STAT pathways. In addition, they reversed the significant changes in the proportions of the gut microbiota induced by DSS. The bioactive compounds contained in H. erythrostictum extracts have sufficient potential for use as natural therapeutic agents for the treatment of IBD in humans. Conclusion: Our results suggest that HEWE and HEBE are highly effective in reducing intestinal inflammation and thus have the potential to be viable therapeutic agents for the treatment of gut inflammation. Clinical trial number: Not applicable.
- 14 November 2024
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 24 (1) , 1-19
Open AccessExtracts ofHylotelephiumerythrostictum (miq.) H. Ohba ameliorate intestinal injury by scavenging ROS and inhibiting multiple signaling pathways in Drosophila
Background: The intestinal epithelial barrier is the first line of defense against pathogens and noxious substances entering the body from the outside world. Through proliferation and differentiation, intestinal stem cells play vital roles in tissue regeneration, repair, and the maintenance of intestinal homeostasis. Inflammatory bowel disease (IBD) is caused by the disruption of intestinal homeostasis through the invasion of toxic compounds and pathogenic microorganisms. Hylotelephium erythrostictum (Miq.) H. Ohba (H. erythrostictum) is a plant with diverse pharmacological properties, including antioxidant, anti-inflammatory, antidiabetic, and antirheumatic properties. However, the roles of H. erythrostictum and its bioactive compounds in the treatment of intestinal injury are unknown. Methods: We examined the protective effects of H. erythrostictum water extract (HEWE) and H. erythrostictum butanol extract (HEBE) on Drosophila intestinal injury caused by dextran sodium sulfate (DSS) or Erwinia carotovoracarotovora 15 (Ecc15). Results: Our findings demonstrated that both HEWE and HEBE significantly prolonged the lifespan of flies fed toxic compounds, reduced cell mortality, and maintained intestinal integrity and gut acid‒base homeostasis. Furthermore, both HEWE and HEBE eliminated DSS-induced ROS accumulation, alleviated the increases in antimicrobial peptides(AMPs) and intestinal lipid droplets caused by Ecc15 infection, and prevented excessive ISC proliferation and differentiation by inhibiting the JNK, EGFR, and JAK/STAT pathways. In addition, they reversed the significant changes in the proportions of the gut microbiota induced by DSS. The bioactive compounds contained in H. erythrostictum extracts have sufficient potential for use as natural therapeutic agents for the treatment of IBD in humans. Conclusion: Our results suggest that HEWE and HEBE are highly effective in reducing intestinal inflammation and thus have the potential to be viable therapeutic agents for the treatment of gut inflammation. Clinical trial number: Not applicable.
- 13 November 2024
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 52 (1) , 51-65
Rab1 and Syntaxin 17 regulate hematopoietic homeostasis through β-integrin trafficking in Drosophila
- 13 November 2024
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 52 (1) , 51-65
Rab1 and Syntaxin 17 regulate hematopoietic homeostasis through β-integrin trafficking in Drosophila
- 22 August 2024
- Published by Elsevier in Insect Biochemistry and Molecular Biology
- Vol. 173, 104176
Notch signaling promotes differentiation, cell death and autophagy in Drosophila hematopoietic system
- 22 August 2024
- Published by Elsevier in Insect Biochemistry and Molecular Biology
- Vol. 173, 104176
Notch signaling promotes differentiation, cell death and autophagy in Drosophila hematopoietic system